Improving the safety of oral immunotherapy for food allergy
Open Access
- 22 December 2015
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 27 (2), 117-125
- https://doi.org/10.1111/pai.12510
Abstract
Food allergy is a major public health problem in children, impacting upon the affected individual, their families and others charged with their care, for example educational establishments, and the food industry. In contrast to most other paediatric diseases, there is no established cure: current management is based upon dietary avoidance and the provision of rescue medication in the event of accidental reactions, which are common. This strategy has significant limitations and impacts adversely on health-related quality of life. In the last decade, research into disease-modifying treatments for food allergy has emerged, predominantly for peanut, egg and cow's milk. Most studies have used the oral route (oral immunotherapy, OIT), in which increasing amounts of allergen are given over weeks-months. OIT has proven effective to induce immune modulation and desensitization' - that is, an increase in the amount of food allergen that can be consumed, so long as regular (typically daily) doses are continued. However, its ability to induce permanent tolerance once ongoing exposure has stopped seems limited. Additionally, the short- and long-term safety of OIT is often poorly reported, raising concerns about its implementation in routine practice. Most patients experience allergic reactions and, although generally mild, severe reactions have occurred. Long-term adherence is unclear, which rises concerns given the low rates of long-term tolerance induction. Current research focuses on improving current limitations, especially safety. Strategies include alternative routes (sublingual, epicutaneous), modified hypoallergenic products and adjuvants (anti-IgE, pre-/probiotics). Biomarkers of safe/successful OIT are also under investigation.Keywords
Funding Information
- Medical Research Council (MR/K010468/1)
- National Institute for Health Research
This publication has 94 references indexed in Scilit:
- Oral Immunotherapy for Treatment of Egg Allergy in ChildrenNew England Journal of Medicine, 2012
- Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized MicePLOS ONE, 2012
- FAST: towards safe and effective subcutaneous immunotherapy of persistent life‐threatening food allergiesClinical and Translational Allergy, 2012
- The safety and efficacy of sublingual and oral immunotherapy for milk allergyJournal of Allergy and Clinical Immunology, 2011
- Dietary baked milk accelerates the resolution of cow’s milk allergy in childrenJournal of Allergy and Clinical Immunology, 2011
- Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergyJournal of Allergy and Clinical Immunology, 2011
- Mechanisms underlying differential food allergy response to heated eggJournal of Allergy and Clinical Immunology, 2011
- Mechanisms of immune tolerance relevant to food allergyJournal of Allergy and Clinical Immunology, 2011
- Clinical efficacy and immune regulation with peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2009
- New Perspectives for Use of Native and Engineered Recombinant Food Proteins in Treatment of Food AllergyImmunology and Allergy Clinics of North America, 2007